Company profile: Vantis Vascular
1.1 - Company Overview
Company description
- Provider of vascular intervention technology for complex arteries, offering the DuoPROβ’ system to navigate tortuous, calcific, and stented arteries and deliver therapeutic devices to distal coronary or peripheral anatomies. Features include the Seamless Profile low-profile tapered design, an inner microcatheter with pushability and atraumatic tip, and an outer delivery catheter enabling smooth navigation and delivery to distal lesions.
Products and services
- DuoPROβ’ Technology: Engineers a system to traverse tortuous, calcific, and stented arteries, enabling delivery of therapeutic devices to distal coronary or peripheral anatomies (stented-arteryβcapable)
- Outer Delivery Catheter: Operates with the inner microcatheter to supply smooth navigation and delivery of interventional devices to distal lesions (interventional-deviceβdelivery)
- Inner Microcatheter: Delivers pushability to traverse calcific and tortuous anatomies, featuring an atraumatic tip to prevent vessel damage (atraumatic-tipped)
Key contacts
π
π
Financial details
π
1.2 - Competitors and similar companies to Vantis Vascular
GB Sciences
HQ: United States
Website
- Description: Provider of research and biotechnical development focused on plant-based therapeutics, including the PhAROS AI drug discovery platform to identify and predict active ingredients; therapies for Parkinsonβs disease (animal proof-of-concept, US patent); COVID-related cytokine release syndrome therapies (positive proof-of-concept); and oral nanoparticle pain therapeutics (US patent, ongoing animal studies).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full GB Sciences company profile β
Celera
HQ: United States
Website
- Description: Provider of molecular diagnostic products and services that leverage knowledge of human variability to personalize disease management, enabling hospitals and clinical laboratories to detect, characterize, monitor, and select treatment for disease, including genotyping for infections diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Celera company profile β
CircuLite
HQ: United States
Website
- Description: Provider of minimally-invasive micro-pumps for long-term partial circulatory support to treat chronic heart failure, supplementing a patient's native pumping capacity and enabling a proactive, lower-risk treatment approach.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full CircuLite company profile β
Transcatheter Technologies
HQ: Germany
Website
- Description: Provider of a unique, repositionable transcatheter aortic valve implantation system designed to increase the safety and durability of aortic valve implantation. Its TRINITY transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Transcatheter Technologies company profile β
Terumo Aortic
HQ: United Kingdom
Website
- Description: Provider of vascular and cardiovascular grafts and aortic repair solutions, designing and manufacturing sealed woven and knitted polyester grafts and devices for surgical, endovascular and hybrid aortic repair. Offerings include Thoraflex Hybrid, RelayPro for thoracic aortic disease, TREO for abdominal aortic aneurysms, and cardiothoracic and thoracoabdominal surgical designs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: βββββ
- Total funding raised: $βββm
- Backers: ββββββββββ
- Acquisitions: ββ
View full Terumo Aortic company profile β
π
2.M&A buyers
2.1 Potential strategic acquirers in the sector
π
π
π
π
View all strategic buyers with complete profiles
Start Free Trial β
2.2 - Strategic buyer groups for Vantis Vascular
π
Buyer group 1: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 2: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π
Buyer group 3: ββββββββ ββββββββ
ββ companies
Description: ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ ββββββββ
Key Products: ββββββββ, ββββββββ, ββββββββ, ββββββββ
π
View all companies in this group
Request Free Trial Now β
π Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial β
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vantis Vascular
2.2 - Growth funds investing in similar companies to Vantis Vascular
π
View all growth equity funds with complete profiles
Start Free Trial β
4 - Top valuation comps for Vantis Vascular
4.2 - Public trading comparable groups for Vantis Vascular
π Unlock all public trading comparable groups with complete valuation data
Start Free Trial β